National Research Gelecekteki Büyüme

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak National Research yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

NasdaqGS:NRC - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
9/30/2024	144	27	N/A	N/A	N/A
6/30/2024	146	29	23	40	N/A
3/31/2024	147	30	26	42	N/A
12/31/2023	149	31	22	38	N/A
9/30/2023	149	29	21	35	N/A
6/30/2023	148	29	21	35	N/A
3/31/2023	150	30	25	36	N/A
12/31/2022	152	32	26	36	N/A
9/30/2022	152	35	31	40	N/A
6/30/2022	152	36	32	39	N/A
3/31/2022	151	37	33	40	N/A
12/31/2021	148	37	41	46	N/A
9/30/2021	144	36	45	50	N/A
6/30/2021	140	36	47	52	N/A
3/31/2021	135	35	45	50	N/A
12/31/2020	133	37	37	41	N/A
9/30/2020	131	38	33	36	N/A
6/30/2020	130	36	35	39	N/A
3/31/2020	130	36	35	39	N/A
12/31/2019	128	32	36	41	N/A
9/30/2019	126	31	38	43	N/A
6/30/2019	124	30	32	38	N/A
3/31/2019	120	31	33	39	N/A
12/31/2018	120	30	34	40	N/A
9/30/2018	119	29	26	33	N/A
6/30/2018	118	26	N/A	36	N/A
3/31/2018	118	24	N/A	28	N/A
12/31/2017	118	23	N/A	28	N/A
9/30/2017	116	22	N/A	30	N/A
6/30/2017	114	23	N/A	26	N/A
3/31/2017	112	21	N/A	31	N/A
12/31/2016	109	20	N/A	27	N/A
9/30/2016	107	21	N/A	25	N/A
6/30/2016	106	20	N/A	24	N/A
3/31/2016	104	19	N/A	25	N/A
12/31/2015	102	17	N/A	22	N/A
9/30/2015	101	16	N/A	20	N/A
6/30/2015	100	16	N/A	24	N/A
3/31/2015	99	16	N/A	23	N/A
12/31/2014	99	18	N/A	26	N/A
9/30/2014	97	18	N/A	25	N/A
6/30/2014	95	17	N/A	25	N/A
3/31/2014	94	16	N/A	21	N/A
12/31/2013	93	15	N/A	19	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: Insufficient data to determine if NRC's forecast earnings growth is above the savings rate (2.5%).

Kazançlar ve Piyasa: Insufficient data to determine if NRC's earnings are forecast to grow faster than the US market

Yüksek Büyüme Kazançları: Insufficient data to determine if NRC's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: Insufficient data to determine if NRC's revenue is forecast to grow faster than the US market.

Yüksek Büyüme Geliri: Insufficient data to determine if NRC's revenue is forecast to grow faster than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if NRC's Return on Equity is forecast to be high in 3 years time

National Research Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Recent updates

Third quarter dividend of US$0.12 announced

Third quarter 2024 earnings released: EPS: US$0.24 (vs US$0.32 in 3Q 2023)

National Research Corporation Appoints Helen L. Hrdy as Chief Operating Officer

Upcoming dividend of US$0.12 per share

NRC Health Launches First Ai-Enabled Solutions to Elevate Healthcare Experience

Dividend of US$0.12 announced

Second quarter 2024 earnings released: EPS: US$0.26 (vs US$0.30 in 2Q 2023)

National Research Corporation (NasdaqGS:NRC) acquired Nobl, Inc. for $7 million.

National Research (NASDAQ:NRC) Is Due To Pay A Dividend Of $0.12

National Research Corporation's (NASDAQ:NRC) Shares May Have Run Too Fast Too Soon

Now 22% undervalued after recent price drop

Dividend of US$0.12 announced

Estimating The Fair Value Of National Research Corporation (NASDAQ:NRC)

First quarter 2024 earnings released: EPS: US$0.27 (vs US$0.28 in 1Q 2023)

National Research Corporation Declares a Quarterly Cash Dividend, Payable on July 15, 2024

National Research Corporation to Report Q1, 2024 Results on May 07, 2024

National Research Corporation, Annual General Meeting, May 08, 2024

Jennifer Baron Joins NRC Health as Its First Chief Experience Officer

Upcoming dividend of US$0.12 per share

Full year 2023 earnings released: EPS: US$1.26 (vs US$1.28 in FY 2022)

National Research's (NASDAQ:NRC) Dividend Will Be $0.12

Dividend of US$0.12 announced

National Research Corporation Announces the Retirement of Kevin Karas as Chief Financial Officer, Effective March 31, 2024

Full year 2023 earnings released: EPS: US$1.26 (vs US$1.28 in FY 2022)

National Research Corporation Declares Quarterly Cash Dividend, Payable on April 15, 2024

National Research Corporation to Report Q4, 2023 Results on Feb 13, 2024

National Research Corporation Announces Executive Appointments

Insider recently sold US$15m worth of stock

Upcoming dividend of US$0.12 per share at 1.2% yield

Founder recently sold US$2.3m worth of stock

National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

New minor risk - Insider selling

National Research Corporation Declares Quarterly Dividend, Payable on January 12, 2024

Founder notifies of intention to sell stock

Third quarter 2023 earnings released: EPS: US$0.32 (vs US$0.34 in 3Q 2022)

National Research Corporation to Report Q3, 2023 Results on Nov 07, 2023

Many Would Be Envious Of National Research's (NASDAQ:NRC) Excellent Returns On Capital

Upcoming dividend of US$0.12 per share at 1.0% yield

Upcoming dividend of US$1.00 per share at 1.1% yield

National Research Corporation Declares Special Dividend, Payable on September 22, 2023

National Research Corporation Declares Quarterly Dividend, Payable on October 13, 2023

Second quarter 2023 earnings released: EPS: US$0.30 (vs US$0.33 in 2Q 2022)

National Research Corporation to Report Q2, 2023 Results on Aug 01, 2023

We Think National Research (NASDAQ:NRC) Can Stay On Top Of Its Debt

Upcoming dividend of US$0.12 per share at 1.9% yield

Founder recently sold US$1.5m worth of stock

Founder recently sold US$954k worth of stock

Founder recently sold US$1.3m worth of stock

National Research Corporation Declares Quarterly Dividend, Payable on July 14, 2023

Why We Like The Returns At National Research (NASDAQ:NRC)

First quarter 2023 earnings released: EPS: US$0.28 (vs US$0.34 in 1Q 2022)

Founder recently sold US$59k worth of stock

Chief Operating Officer recently sold US$1.1m worth of stock

Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?

Upcoming dividend of US$0.12 per share at 1.9% yield

Senior VP of Finance recently sold US$544k worth of stock

Founder recently sold US$292k worth of stock

Full year 2022 earnings released: EPS: US$1.28 (vs US$1.47 in FY 2021)

National Research Corporation Declares Quarterly Cash Dividend, Payable on April 14, 2023

National Research Corporation to Report Q4, 2022 Results on Feb 14, 2023

Founder recently sold US$259k worth of stock

Founder exercised options to buy US$439k worth of stock.

Upcoming dividend of US$0.12 per share

National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

National Research Corporation Declares Quarterly Dividend, Payable on January 13, 2023

Third quarter 2022 earnings released: EPS: US$0.34 (vs US$0.38 in 3Q 2021)

Founder recently sold US$1.8m worth of stock

Founder recently sold US$1.8m worth of stock

Chief Operating Officer exercised options and sold US$339k worth of stock

Upcoming dividend of US$0.24 per share

National Research Corp: Market Is Discounting These Key Factors

Founder recently sold US$3.9m worth of stock

National Research Corporation Declares Quarterly Dividend, Payable on October 14, 2022

National Research declares $0.24 dividend

Now 20% undervalued